Dravet Syndrome – Clinical Trial

International Clinical Trial

Publication pending

Tuberous Sclerosis Complex

International Clinical Trial

Publication pending

Enriched Cannabidiol Oil, in Children and Adolescents with Medication Resistant, Refractory Epilepsy

Melbourne Brain Centre

Publication pending

Australia Medicinal Cannabis Study

University of Melbourne, Lambert Initiative for Cannabinoid Therapeutics

Publication pending

A Study to Investigate the Efficacy and Safety of Cannabidiol in Children and Young Adults with Dravet Syndrome

GW Research Ltd

Publication pending

International clinical trial – Tuberous Sclerosis Complex

The GW Pharmaceuticals partnership has allowed NSW children and young people with the rare disorder Tuberous Sclerosis Complex (TSC) to take part in the GW-sponsored international clinical trial evaluating the use of Epidiolex® in treating their seizures. This Phase III global study, allows 210 patients access to Epidiolex®, in which 12 children in NSW are participating, through the SCHN, Clinical Research Centre.

Publication pending

Rett Syndrome Clinical Trial

Sydney Children’s Hospital Network

Publication pending

Cannabis-based products for pediatric epilepsy

An up-to-date summary of the benefits and harms of cannabis-based products for epilepsy in children.

Research findings

Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis.

This paper aimed to systematically examine the efficacy and adverse event profile of cannabidiol and medicinal cannabis.

Research findings

Exploring the effects of THC and CBD on simulated driving

The Lambert Initiative at the University of Sydney, Royal Prince Alfred.

Publication pending

Knowledge and attitudes of Australian general practitioners towards medicinal cannabis

The Lambert Initiative at the University of Sydney, Royal Prince Alfred Hospital and Tilray.

Research findings

Cannabis as Medicine Survey (CAMS16)

The Lambert Initiative at the University of Sydney and South East Sydney Local Health District.

Research findings


Hi there!

Great!

Great!

Got a question?

Want to register for a call back from a Specialist Registered Nurse (Cannabinoid Therapeutics)?

    Add your details below and a nurse will contact you within 5 business days.

    Thanks! One of our Specialist Registered Nurses will be in contact with you shortly.